Parliamentary Group against Antimicrobial Resistance (PKAMR): strengthening antibiotic innovation, ensuring access
On June 12, 2026, the Parliamentary Group against Antimicrobial Resistance (PKAMR) held a discussion under the title "High-tech agenda for antibiotics—strategic directions for innovation and security of supply". The discussion focused on how Germany can ensure its research, development, and production capacities for antibiotics are future-proof.
The topics "Resistance is increasingly threatening healthcare," "Research is strong, but scaling remains a weak point," "A lack of market incentives is slowing innovation," and "Strengthen supply chains and reduce dependencies," were discussed by the following members:
The discussion focused on four key topics:
- The growing threat of antimicrobial resistance;
- Challenges in scaling antibiotic innovation;
- Insufficient market incentives for antibiotic development;
- Strengthening supply chains and reducing dependencies.
Contributions were provided by:
- Dr. Franziska Kersten (Member of the Bundestag), Vice Chair of the PKAMR
- Prof. Dr. Rolf Müller, Executive Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and scientist in the research area Novel Antibiotics of the German Center for Infection Research (DZIF)
- Dr. Holger Zimmermann, Managing Director of the early-stage incubator INCATE
- Johanna Wegenaer, Manager Government Affairs at GSK
More information can be found in the German-language news release of the German Network against Antimicrobial Resistance (Deutsches Netzwerk gegen Antimikrobielle Resistenzen, DNAMR) and the DZIF.
